FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566895627> ?p ?o ?g. }

• W2566895627 endingPage "319" @default.
• W2566895627 startingPage "311" @default.
• W2566895627 abstract "The development of anti-drug antibodies against tumor necrosis factor inhibitors is a likely explanation for the failure of TNF-inhibitors in patients with spondyloarthritis. Our study determined the existence and clinical implications of ADAbs in axial spondyloarthritis patients.According to the Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis, patients treated with adalimumab or infliximab were recruited consecutively. Serum samples were collected at enrollment to measure anti-drug antibodies and drug levels.Of 100 patients, the mean duration of current TNF inhibitor use was 22.3±17.9 months. Anti-drug antibodies were detected in 5 of 72 adalimumab users compared to 5 of 28 infliximab users (6.9% vs. 17.9%). Anti-drug antibodies-positive patients had a significantly higher body mass index than anti-drug antibodies-negative patients among both adalimumab (28.4±5.9kg/m2 vs. 24.3±2.9kg/m2, respectively, p=0.01) and infliximab users (25.9±2.8kg/m2 vs. 22.6±2.8kg/m2, respectively, p=0.02). During the median 15-month follow-up period, drug discontinuation occurred more frequently in the anti-drug antibodies-positive group than the anti-drug antibodies-negative group (30.0% vs. 6.5%, respectively, p=0.04). In logistic regression, anti-drug antibodies positivity (OR=5.85, 95% CI 1.19-28.61, p=0.029) and body mass index (OR=4.35, 95% CI 1.01-18.69, p=0.048) were associated with a greater risk of stopping TNF inhibitor treatment.Our result suggests that the presence of anti-drug antibodies against adalimumab and infliximab as well as a higher body mass index can predict subsequent drug discontinuation in axial spondyloarthritis patients." @default.
• W2566895627 created "2017-01-06" @default.
• W2566895627 creator A5013938534 @default.
• W2566895627 creator A5021682141 @default.
• W2566895627 creator A5063002351 @default.
• W2566895627 creator A5071811721 @default.
• W2566895627 creator A5075552990 @default.
• W2566895627 creator A5076443181 @default.
• W2566895627 creator A5083718698 @default.
• W2566895627 creator A5085504469 @default.
• W2566895627 date "2017-07-01" @default.
• W2566895627 modified "2023-10-16" @default.
• W2566895627 title "Higher body mass index and anti-drug antibodies predict the discontinuation of anti-TNF agents in Korean patients with axial spondyloarthritis" @default.
• W2566895627 cites W1196914128 @default.
• W2566895627 cites W1966756689 @default.
• W2566895627 cites W1969216944 @default.
• W2566895627 cites W1990305566 @default.
• W2566895627 cites W1992751771 @default.
• W2566895627 cites W1997999969 @default.
• W2566895627 cites W1999140409 @default.
• W2566895627 cites W2017883234 @default.
• W2566895627 cites W2019688614 @default.
• W2566895627 cites W2026368825 @default.
• W2566895627 cites W2039804759 @default.
• W2566895627 cites W2043261411 @default.
• W2566895627 cites W2052047947 @default.
• W2566895627 cites W2081388746 @default.
• W2566895627 cites W2082375916 @default.
• W2566895627 cites W2090576783 @default.
• W2566895627 cites W2090685459 @default.
• W2566895627 cites W2094250341 @default.
• W2566895627 cites W2095161324 @default.
• W2566895627 cites W2097271053 @default.
• W2566895627 cites W2108090439 @default.
• W2566895627 cites W2110732019 @default.
• W2566895627 cites W2122042072 @default.
• W2566895627 cites W2124551692 @default.
• W2566895627 cites W2125389744 @default.
• W2566895627 cites W2125412490 @default.
• W2566895627 cites W2125889316 @default.
• W2566895627 cites W2134803931 @default.
• W2566895627 cites W2136775453 @default.
• W2566895627 cites W2147791981 @default.
• W2566895627 cites W2156605473 @default.
• W2566895627 cites W2162311979 @default.
• W2566895627 cites W2165890913 @default.
• W2566895627 cites W2314052274 @default.
• W2566895627 cites W3172478362 @default.
• W2566895627 doi "https://doi.org/10.1016/j.rbre.2016.11.009" @default.
• W2566895627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28743358" @default.
• W2566895627 hasPublicationYear "2017" @default.
• W2566895627 type Work @default.
• W2566895627 sameAs 2566895627 @default.
• W2566895627 citedByCount "3" @default.
• W2566895627 countsByYear W25668956272020 @default.
• W2566895627 countsByYear W25668956272021 @default.
• W2566895627 countsByYear W25668956272022 @default.
• W2566895627 crossrefType "journal-article" @default.
• W2566895627 hasAuthorship W2566895627A5013938534 @default.
• W2566895627 hasAuthorship W2566895627A5021682141 @default.
• W2566895627 hasAuthorship W2566895627A5063002351 @default.
• W2566895627 hasAuthorship W2566895627A5071811721 @default.
• W2566895627 hasAuthorship W2566895627A5075552990 @default.
• W2566895627 hasAuthorship W2566895627A5076443181 @default.
• W2566895627 hasAuthorship W2566895627A5083718698 @default.
• W2566895627 hasAuthorship W2566895627A5085504469 @default.
• W2566895627 hasBestOaLocation W25668956271 @default.
• W2566895627 hasConcept C126322002 @default.
• W2566895627 hasConcept C159654299 @default.
• W2566895627 hasConcept C17991360 @default.
• W2566895627 hasConcept C203014093 @default.
• W2566895627 hasConcept C2777138892 @default.
• W2566895627 hasConcept C2778715236 @default.
• W2566895627 hasConcept C2780035454 @default.
• W2566895627 hasConcept C2780132546 @default.
• W2566895627 hasConcept C2780221984 @default.
• W2566895627 hasConcept C71924100 @default.
• W2566895627 hasConcept C90924648 @default.
• W2566895627 hasConcept C98274493 @default.
• W2566895627 hasConceptScore W2566895627C126322002 @default.
• W2566895627 hasConceptScore W2566895627C159654299 @default.
• W2566895627 hasConceptScore W2566895627C17991360 @default.
• W2566895627 hasConceptScore W2566895627C203014093 @default.
• W2566895627 hasConceptScore W2566895627C2777138892 @default.
• W2566895627 hasConceptScore W2566895627C2778715236 @default.
• W2566895627 hasConceptScore W2566895627C2780035454 @default.
• W2566895627 hasConceptScore W2566895627C2780132546 @default.
• W2566895627 hasConceptScore W2566895627C2780221984 @default.
• W2566895627 hasConceptScore W2566895627C71924100 @default.
• W2566895627 hasConceptScore W2566895627C90924648 @default.
• W2566895627 hasConceptScore W2566895627C98274493 @default.
• W2566895627 hasIssue "4" @default.
• W2566895627 hasLocation W25668956271 @default.
• W2566895627 hasLocation W25668956272 @default.
• W2566895627 hasLocation W25668956273 @default.
• W2566895627 hasOpenAccess W2566895627 @default.
• W2566895627 hasPrimaryLocation W25668956271 @default.
• W2566895627 hasRelatedWork W1968760412 @default.

• next